Literature DB >> 6298276

Typing of clinical herpes simplex virus isolates with mouse monoclonal antibodies to herpes simplex virus types 1 and 2: comparison with type-specific rabbit antisera and restriction endonuclease analysis of viral DNA.

E Peterson, O W Schmidt, L C Goldstein, R C Nowinski, L Corey.   

Abstract

A total of 122 clinical isolates of herpes simplex virus (HSV) from 107 patients were typed by using an indirect immunoperoxidase technique with commercially available type-specific rabbit antisera, recently developed mouse monoclonal antibodies to HSV types 1 and 2, and restriction endonuclease analysis of viral DNA. With the commercially available type-specific rabbit antisera, 34% of clinical HSV isolates were of indeterminate type; 63% of them were typed as HSV type 1 and 37% as HSV type 2 by using monoclonal antibody and restriction enzyme typing systems. Typing by immunofluorescence assay with the monoclonal antibodies gave identical results to those obtained by restriction enzyme analysis. Simultaneous infection with both HSV types was demonstrated by monoclonal antibody typing in five isolates from three patients. These findings were subsequently confirmed by plaque purification and restriction endonuclease analysis of viral DNA. Monoclonal antibodies were as sensitive as restriction enzyme analysis for the typing of clinical HSV isolates. Because of their simplicity, they are more amenable to use in clinical laboratories than is restriction endonuclease analysis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6298276      PMCID: PMC272580          DOI: 10.1128/jcm.17.1.92-96.1983

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  17 in total

1.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

2.  The isolation of hybrid cell lines producing monoclonal antibodies against the p15(E) protein of ecotropic murine leukemia viruses.

Authors:  R C Nowinski; M E Lostrom; M R Tam; M R Stone; W N Burnette
Journal:  Virology       Date:  1979-02       Impact factor: 3.616

3.  Membrane proteins specified by herpes simplex viruses. I. Identification of four glycoprotein precursors and their products in type 1-infected cells.

Authors:  P G Spear
Journal:  J Virol       Date:  1976-03       Impact factor: 5.103

4.  Restriction endonuclease fingerprinting of herpes simplex virus DNA: a novel epidemiological tool applied to a nosocomial outbreak.

Authors:  T G Buchman; B Roizman; G Adams; B H Stover
Journal:  J Infect Dis       Date:  1978-10       Impact factor: 5.226

5.  Isolation of viruses, bacteria and other organisms from venereal disease clinic patients: methodology and problems associated with multiple isolations.

Authors:  B B Wentworth; P Bonin; K K Holmes; L Gutman; P Wiesner; E R Alexander
Journal:  Health Lab Sci       Date:  1973-04

6.  Rapid typing of herpes simplex virus strains using the indirect immunoperoxidase method.

Authors:  D R Benjamin
Journal:  Appl Microbiol       Date:  1974-10

7.  Relation of pock size on chorioallantoic membrane to antigenic type of herpesvirus hominis.

Authors:  A J Nahmias; W R Dowdle; Z M Naib; A Highsmith; R W Harwell; W E Josey
Journal:  Proc Soc Exp Biol Med       Date:  1968-04

8.  A rapid technique for distinguishing herpes-simplex virus type 1 from type 2 by restriction-enzyme technology.

Authors:  D M Lonsdale
Journal:  Lancet       Date:  1979-04-21       Impact factor: 79.321

9.  Clinical and virological studies on genital herpes.

Authors:  T Kawana; T Kawaguchi; S Sakamoto
Journal:  Lancet       Date:  1976-10-30       Impact factor: 79.321

10.  Virological studies in genital herpes.

Authors:  I W Smith; J F Peutherer; D H Robertson
Journal:  Lancet       Date:  1976-11-13       Impact factor: 79.321

View more
  24 in total

1.  Clear detection and typing of herpes simplex virus types 1 and 2 by an indirect ELISA assay: comparison with three different combined methods--capture ELISA, restriction enzymes, and polymerase chain reaction.

Authors:  P Markoulatos; P Fountoucidou; G Marinakis; V Krikelis; N Spyrou; N Vamvakopoulos; M L Moncany
Journal:  J Clin Lab Anal       Date:  1997       Impact factor: 2.352

2.  Enhanced malignant transformation induced by expression of a distinct protein domain of ribonucleotide reductase large subunit from herpes simplex virus type 2.

Authors:  M A Ali; D McWeeney; A Milosavljevic; J Jurka; R J Jariwalla
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

3.  Evaluation of a quantitative competitive PCR assay for measuring herpes simplex virus DNA content in genital tract secretions.

Authors:  A Hobson; A Wald; N Wright; L Corey
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

4.  Rapid diagnosis of cytomegalovirus by indirect immunofluorescence assay with monoclonal antibody F6b in a commercially available kit.

Authors:  G Lucas; J M Seigneurin; J Tamalet; S Michelson; M Baccard; J F Delagneau; P Deletoille
Journal:  J Clin Microbiol       Date:  1989-02       Impact factor: 5.948

5.  Detection and serotyping of herpes simplex virus in MRC-5 cells by use of centrifugation and monoclonal antibodies 16 h postinoculation.

Authors:  C A Gleaves; D J Wilson; A D Wold; T F Smith
Journal:  J Clin Microbiol       Date:  1985-01       Impact factor: 5.948

6.  Comparison of a commercial ELISA system with restriction endonuclease analysis for typing herpes simplex virus.

Authors:  K J Smith; C R Ashley; J M Darville; J Harbour; A Roome
Journal:  J Clin Pathol       Date:  1984-08       Impact factor: 3.411

7.  Evaluation of a latex agglutination test for herpes simplex virus.

Authors:  G A Storch; C A Reed; Z A Dalu
Journal:  J Clin Microbiol       Date:  1988-04       Impact factor: 5.948

8.  Rapid identification and typing of herpes simplex virus by a new enzyme immunoassay with peroxidase-labeled complement C1q.

Authors:  S M Lee; F Taguchi
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

9.  Cervical antibodies in patients with oral herpes simplex virus type 1 (HSV-1) infection: local anamnestic responses after genital HSV-2 infection.

Authors:  R Ashley; A Wald; L Corey
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

10.  Comparison of intramuscular recombinant alpha interferon (rIFN-2A) with topical acyclovir for the treatment of first-episode herpes genitalis and prevention of recurrences.

Authors:  M J Levin; F N Judson; L Eron; Y J Bryson; L Corey; M Murray; R R Scheer
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.